Sector Update: Health Care Stocks Higher Late Afternoon

MT Newswires Live11-27

Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 0.5% and the Health Care Select Sector SPDR Fund (XLV) up 0.3%.

The iShares Biotechnology ETF (IBB) was marginally higher.

In corporate news, Pulse Biosciences (PLSE) shares jumped nearly 12% after board Co-Chair Robert Duggan, the controlling stockholder, informed management he may increase his stake in the company.

Spectral AI (MDAI) shares surged past 19%. The company said Tuesday it has repriced about 8.4 million warrants with an exercise price of $11.50 per share to $2.75 per share, effective following its 20-day notice requirement.

Arrowhead Pharmaceuticals (ARWR) shares popped 12%. The company signed a global licensing and partnership agreement with Sarepta Therapeutics (SRPT) to develop new therapies for genetic diseases of the muscle, central nervous system and lungs. Sarepta shares climbed 12%.

Amgen (AMGN) shares tumbled 5.8%. The company said a phase 2 trial showed that its investigational obesity drug MariTide demonstrated up to 20% average weight loss after a year in people living with obesity or overweight without type 2 diabetes. Mizuho said in a note that this efficacy is "on the low end of expectations."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment